RESUMEN
Tautomycin inhibited the catalytic subunits of protein phosphatase-1 (Kiapp = 0.16 nM) more potently than protein phosphatase 2A (Kiapp = 0.4 nM), and the native forms of these enzymes in mammalian, protozoan and plant extracts were inhibited in a similar manner. Protein phosphatase 2B was inhibited 10,000-fold less potently, while two other phosphatases and six protein kinases were unaffected at 10 microM. Okadaic acid prevented the binding of tautomycin to protein phosphatase 2A, indicating a common binding site for both inhibitors. The different relative potencies of tautomycin and okadaic acid for protein phosphatases 1 and 2A suggest that parallel use of both inhibitors may help to identify physiological substrates for each enzyme.
Asunto(s)
Fosfoproteínas Fosfatasas/antagonistas & inhibidores , Piranos , Compuestos de Espiro , Streptomyces/análisis , Antifúngicos/farmacología , Éteres Cíclicos/farmacología , Técnicas In Vitro , Cinética , Toxinas Marinas , Microcistinas , Ácido Ocadaico , Péptidos Cíclicos/farmacología , Fosforilasas/metabolismo , Proteína Fosfatasa 1 , Proteína Fosfatasa 2RESUMEN
Pyridazomycin, a new antifungal antibiotic produced by Streptomyces violaceoniger sp. griseofuscus (strain Tü 2557), was detected in a selective screening against Mucor hiemalis (Tü 179/180). The amino acid side chain of 1 can be seen as L-ornithine, whose gamma-nitrogen atom is part of a pyridazine ring building a quaternary ammonium system. The structure of 1 was established by spectroscopic analysis of the parent compound and degradation products. The occurrence of a pyridazine ring in microbial secondary metabolites is unique.
Asunto(s)
Antifúngicos/aislamiento & purificación , Fenómenos Químicos , Química , Cromatografía Liquida , Evaluación Preclínica de Medicamentos , Espectroscopía de Resonancia Magnética , Piridazinas/aislamiento & purificación , Piridazinas/farmacología , Espectrofotometría Infrarroja , Streptomyces/análisisAsunto(s)
Inmunosupresores/aislamiento & purificación , Streptomyces/análisis , Animales , Ciclosporinas/farmacología , Depresión Química , Evaluación Preclínica de Medicamentos , Inmunidad Celular/efectos de los fármacos , Inmunosupresores/farmacología , Prueba de Cultivo Mixto de Linfocitos , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Piridinas/aislamiento & purificación , Piridinas/farmacología , TacrolimusAsunto(s)
Inhibidores de la Enzima Convertidora de Angiotensina , Antihipertensivos/farmacología , Animales , Captopril/farmacología , Fenómenos Químicos , Química , Computadores , Venenos de Crotálidos/farmacología , Fermentación , Humanos , Modelos Biológicos , Fósforo , Streptomyces/análisis , Compuestos de Sulfhidrilo/farmacología , AzufreRESUMEN
A novel enzyme inhibitor against RNA-directed DNA polymerase of avian myeloblastosis virus was produced by an isolate of a new streptomycete for which the name Streptomyces retrostaticus is proposed. This enzyme inhibitor, which was named retrostatin, did not inhibit DNA-directed DNA polymerase of Escherichia coli and DNA-directed RNA polymerase of Ehrlich ascites tumor cells. Retrostatin was produced by the microorganism together with streptonigrin. These two substances were extracted from the culture broth with ethyl acetate at acidic pH. Retrostatin is an acidic pH indicator and the free acid was recovered as a red powder. Retrostatin had weak antibiotic activities against Gram-positive bacteria and yeasts.
Asunto(s)
Virus de la Leucosis Aviar/enzimología , Virus de la Mieloblastosis Aviar/enzimología , Inhibidores de la Transcriptasa Inversa , Animales , Bacterias/efectos de los fármacos , Carcinoma de Ehrlich/enzimología , ADN Polimerasa Dirigida por ADN/metabolismo , ARN Polimerasas Dirigidas por ADN/metabolismo , Evaluación Preclínica de Medicamentos , Escherichia coli/enzimología , Hongos/efectos de los fármacos , Ratones , Pruebas de Sensibilidad Microbiana , ADN Polimerasa Dirigida por ARN/aislamiento & purificación , ADN Polimerasa Dirigida por ARN/farmacología , Streptomyces/análisis , Streptomyces/crecimiento & desarrollo , Estreptonigrina/aislamiento & purificación , Estreptonigrina/farmacologíaRESUMEN
Nosiheptide (9671 R.P.) isolated from Streptomyces actuosus 40037 (NRRL 2954) is a sulfur-containing polypeptidic antibiotic, quite different from all the other members of this family. Very active in vitro against gram-positive bacteria, it is inactive in vivo in experimentally infected mice. Not toxic, even at high dose, it may be used as a feed additive for chickens and pigs and it shows a favourable effect on the growth and conversion index.
Asunto(s)
Antibacterianos , Streptomyces/análisis , Alimentación Animal , Animales , Bacterias/efectos de los fármacos , Pollos , Evaluación Preclínica de Medicamentos , Aditivos Alimentarios , Espectrometría de Fluorescencia , Espectrofotometría Infrarroja , Porcinos , Tiazoles/aislamiento & purificación , Tiazoles/farmacologíaRESUMEN
Revistin, a substance that strongly inhibits the reverse transcriptase activity of murine leukemia virus in our screening system, was obtained from a cultured broth of a soil streptomyces which was closely related to Streptomyces filipinensis. The assay method for the activity was based on the inhibition by a test material of the incorporation of 3H-dTMP into DNA synthesized by the reverse transcriptase of an oncogenic RNA virus. Crude revistin was isolated by serial procedures of salting out with ammonium sulfate and precipitation with cetylpyridinium chloride. The crude material showed neither antibacterial nor antifungal activity. It exhibited against splenomegaly in mice caused by Rauscher leukemia virus infection.